Board of Directors
Chairman of the Board
Anne-Mette Hvas (MD, PhD, Professor)
Dean, Faculty of Health, Aarhus University
Anne-Mette is Professor and former Senior Consultant in Clinical Biochemistry as well as member of The Danish Board on Research Misconduct.
Vice Chairman of the Board
Karin Conde-Knape (PhD)
Senior Vice President, Global Drug Discovery, Novo Nordisk A/S
She is driving the early pipeline and innovation within the areas of diabetes, obesity, cardiovascular, renal, rare endocrine and metabolic diseases. She has many years of experience within pharmaceutical industry.
Board members
Gunnar Gíslason (MD, PhD)
Head of Research at the Danish Heart Foundation, Professor of Cardiology at University of Copenhagen and Head of Research at Gentofte Hospital
Gunnar specialises in cardiovascular epidemiology and pharmacoepidemiology. He is dedicated to advancing the field through his work as a researcher and as a spokesperson for the Danish Heart Foundation.
Claus Graff (M.Sc., BME, PhD)
Professor, Aalborg University, Department of Health Science & Technology
He has many years of experience as a researcher within cardiac electrophysiology. His primary focus is to create understanding of the mechanisms of cardiac arrhythmias and the pathological substrate of altered depolarization and repolarization of the heart.
Alicia Lundby (M.Sc., PhD)
Professor MSO, Department of Biomedical Sciences, University of Copenhagen
She has implemented and utilized proteomics and phosphoproteomics strategies to study molecular cardiac regulatory mechanisms for more than a decade.
Rasmus Borgquist (MD, PhD)
Head of Cardiovascular Medicine at the Novo Nordisk Foundation.
Rasmus Borgquist is working to promote and facilitate front-line research in the cardiovascular field. Rasmus is a cardiologist and clinical researcher, and earlier in his career he has also been the Head of Department of Cardiology at Aarhus University Hospital.